SNDX (SNDX) Stock Price & Analysis
SNDX (SNDX) fell 0.58% to USD 20.56 as of September 8, 2026 at 06:23 UTC, according to Nexqual real-time market data.
SNDX last closed at USD 20.56; the session ranged USD 20.46–21 on volume of 1,360,749 shares. Market capitalization is —, with a 52-week range of USD 12.99–25.59 (NMS). Source: Nexqual, September 8, 2026 at 06:23 UTC.
Key Statistics (as of September 8, 2026 at 06:23 UTC)
| Price | USD 20.56 |
|---|---|
| Change | ▼ 0.58% (down) |
| Previous Close | USD 20.56 |
| Open | USD 20.56 |
| Day Range | USD 20.46 – 21 |
| 52-Week Range | USD 12.99 – 25.59 |
| Volume | 1,360,749 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (SNDX)
Nexqual's technical model rates SNDX "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 06:23 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 49.13 (neutral) |
| vs SMA50 | Below (USD 20.95) |
| MACD | -0.02 (negative) |
From SNDX's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KURA | Kura Oncology, Inc. | USD 13.25 | ▲ 1.07% |
| PTGX | Protagonist Therapeutics, Inc. | USD 145.72 | ▼ 0.25% |
| CRNX | Crinetics Pharmaceuticals, Inc. | USD 84.95 | ▲ 0% |
| RGNX | REGENXBIO Inc. | USD 8.94 | ▼ 6.88% |
| REPL | Replimune Group, Inc. | USD 15.04 | ▼ 5.88% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:23 UTC. This page is informational and not investment advice.